战略与国际研究中心-India,-Pakistan,-and-Proliferation-in-the-Middle-East_61页_230kb
报告摘要
Summary of "India, Pakistan, and Proliferation in the Middle East" by Anthony H. Cordesman
Core Content
This document analyzes the proliferation of weapons of mass destruction (WMDs) and unconventional warfare capabilities in the Middle East, focusing on key countries such as Algeria, Libya, Egypt, Israel, and Syria. It highlights the motivations, strategies, and challenges associated with WMD development and use in the region, as well as the implications for arms control and counterproliferation efforts.
Main Views
-
Motivations for Proliferation:
- Prestige, deterrence, and war fighting are primary drivers.
- The "greater Middle East" arms race includes overlap with India-Pakistan and North Korea.
- WMDs are used to compensate for conventional weakness and to intimidate adversaries.
- The "glitter factor" makes WMDs an attractive alternative to expensive conventional investments.
-
War Fighting Options:
- Covert and unconventional methods are preferred.
- Surprise attacks and preemption are common strategies.
- Use of proxies and covert delivery systems is widespread.
- The potential for existential threats is high due to the concentration of populations and leadership in urban areas.
-
Arms Control Challenges:
- Existing arms control regimes (e.g., NPT, CWC, MTCR) are ineffective in preventing proliferation.
- Dual-use technology enables covert WMD development.
- The lack of enforcement mechanisms in the BWC and CWC undermines their effectiveness.
- Even with inspections, proliferation can be concealed and manipulated.
-
Uncertainties in WMD Use:
- Uncertainty in weapon accuracy, reliability, and effectiveness.
- Lack of full operational testing and potential for unattributable attacks.
- Risk of escalation, including "total war" and the use of infectious agents.
- The role of authoritarian leaders in decision-making and the potential for "martyrdom" and irrational escalation.
Key Information
Proliferation is Already Here
| Country | Nuclear | Chemical | Biological | Missiles | Aircraft |
|---|---|---|---|---|---|
| Algeria | Research | ? | ? | No | MiG-23 |
| Libya | Research | Deployed | Research | Scud B | Su-24 |
| Egypt | Research | Stockpile | Research | Scud B | F-16C |
| Israel | 100-200 | Developed | Developed | Jericho II | F-15C |
| Syria | No | Deployed | Developed | Scud C | Su-24 |
| Iran | Developing | Deployed | Deployed | Scud C | Su-24 |
| Iraq | Research | Covert | Covert | Covert | Su-24 |
| Yemen | No | Stockpiled* | No | SS-21* | Su-22 |
*Probably no longer usable.
Case Studies
Algeria
- Delivery Systems: 10 Su-24, 40 MiG-23BN, tube artillery, and possible modifications to SS-N-2B Styx.
- Chemical Weapons: Possible development, no evidence of deployment.
- Biological Weapons: Early research, no production capability.
- Nuclear Weapons: Covert nuclear research program with Chinese support. Built a research reactor (Es Salam), but halted further progress due to public exposure and Western pressure.
Libya
- Delivery Systems: Scud B, FROG-7, Tu-22, Su-24, and Mirage 5D/DE.
- Chemical Weapons: Has produced mustard and nerve gas. Has a main production facility at Rabta with capacity for 100 metric tons per year.
- Biological Weapons: Early research, no production capability.
- Nuclear Weapons: Attempted to acquire nuclear weapons from China, has a 10-megawatt reactor, but no active nuclear weapons program.
Egypt
- Delivery Systems: Scud B, Saqr 80, FROG-7, and various fighter aircraft.
- Chemical Weapons: Has mustard and nerve gas stockpiles and production facilities. Conducted field exercises in chemical defense.
- Biological Weapons: Research and technical base, but no active production.
- Nuclear Weapons: Basic research in uranium enrichment and fuel fabrication. May have a stockpile of 60-80 plutonium weapons and up to 200-300 nuclear weapons.
Israel
- Delivery Systems: Jericho I and II missiles, F-15, F-16, and other aircraft, Lance missile launchers.
- Chemical Weapons: Developed but not deployed. Has extensive chemical defense systems.
- Biological Weapons: Research capabilities, but no active production.
- Nuclear Weapons: Estimated stockpile of 100-200 weapons. Has a nuclear research reactor and weapons design facilities.
Syria
- Delivery Systems: Scud B, Scud C, SS-21, and Mirage 5D/DE, Su-24.
- Chemical Weapons: Deployed, with significant capabilities.
- Biological Weapons: Developing, with potential for mass production.
- Nuclear Weapons: No evidence of nuclear weapons, but has a research reactor and some nuclear research.
Missile Defenses
- Israel: Deploying Arrow 2 and developing PAC-3 and Rafale AB-10 systems. These are designed to intercept missiles at reentry or exoatmospheric altitudes, covering up to 85% of the population.
- Advanced Intelligence Systems: Israel has launched satellites (Shavit, Ofeq) for surveillance and intelligence gathering, especially targeting Iran, Syria, and Iraq.
Strategy, Tactics, and Operations
- Middle Eastern states have highly variable strategies and tactics.
- Israel is the only state with detailed war plans and tactical employment concepts.
- Most states focus on acquisition and concealment rather than actual employment.
- WMD forces are often compartmentalized and under the control of ruling elites.
- Actual employment is crisis-driven and not well planned, with limited testing and operational readiness.
Counterproliferation
- Counterproliferation efforts are hindered by the lack of meaningful arms control regimes.
- The risk of escalation and the use of proxies and unconventional warfare complicate counterproliferation strategies.
- The need for improved intelligence and surveillance systems is critical to countering WMD proliferation.
Major Uncertainties
- Weapon accuracy, reliability, and effectiveness remain uncertain.
- Lack of full operational testing and the "Heisenberg factor" contribute to unpredictability.
- The potential for unattributable attacks and proxy warfare increases instability.
- Authoritarian leaderships may make irrational decisions during crises.
- The risk of "total war" and the use of infectious agents is significant.
- The development of "cocktail" WMDs (mixtures of agents) adds to the complexity.
- The long-term impact on regional stability and conventional warfare is unclear.
Conclusion
The proliferation of WMDs in the Middle East is a complex and multifaceted issue, driven by regional rivalries, strategic imperatives, and the desire for deterrence. Despite arms control efforts, the region's states continue to develop and conceal WMD capabilities, often using unconventional and covert methods. The lack of effective international oversight and the volatility of regional dynamics make counterproliferation a significant challenge. The document emphasizes the need for more robust and intrusive inspection regimes, better intelligence capabilities, and a comprehensive approach to managing the risks of WMD proliferation.
试读结束,高清完整版pdf/doc/ppt,请点下载